PMVP

PMV Pharmaceuticals, Inc. · NASDAQ

Sector Health Technology
Industry Biotechnology
Website mvpharma.com
Employees(FY) 62
ISIN US69353Y1038

Performance

-5.99%

-0.63%

+1.29%

-25.24%

-49.35%

YTD

-36.95%

Profile

PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. The company's lead product candidate is PC14586, a small molecule that corrects mutant p53 protein containing the Y220C mutation and restores wild-type p53 function. It is also developing Wild-type p53 or other p53 mutations, including R273H, R273C, R175H, G245S, R248Q, and R282W, as well as other p53 hotspot mutations. The company was formerly known as PJ Pharmaceuticals, Inc. and changed its name to PMV Pharmaceuticals, Inc. in July 2013. PMV Pharmaceuticals, Inc. was incorporated in 2013 and is headquartered in Cranbury, New Jersey.

Advanced Technical Analysis

Technical Analysis of PMVP 2024-11-20

The stock indicators reflect a bearish sentiment, with the Moving Average Score at 16, Oscillators Score at 36, and a Technical Score of 26, indicating overall weakness in price momentum and suggesting caution for potential investors. The low scores across all categories highlight a lack of bullish signals in the current market environment.

Technical Scores and Rating

Moving Average Score

Oscillator Score

Technical Rating

Stock Analysis of PMVP

Stock Rank

Recent News & Updates

2024-11-06 19:00
PMV Pharmaceuticals Reports Third Quarter 2024 Financial Results(Globenewswire)
2024-10-22 20:00
PMV Pharmaceuticals Provides a Progress Update on PYNNACLE Clinical Trial(Globenewswire)
2024-08-07 20:00
PMV Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides a Progress Update on PYNNACLE Clinical Trial(Globenewswire)
2024-06-02 21:55
Here's Why PMV Pharmaceuticals (PMVP) Could be Great Choice for a Bottom Fisher(Zacks)
2024-05-29 19:00
PMV Pharmaceuticals to Participate at Upcoming Investor Conferences in June(Globenewswire)
2024-05-28 19:00
Foundation Medicine and PMV Pharma Announce Collaboration to Develop Companion Diagnostic for Rezatapopt, a First-In-Class, Investigational, Selective p53 Y220C Reactivator(Yahoo Finance)
2024-05-09 01:54
PMVP Stock Earnings: PMV Pharma Beats EPS for Q1 2024(Investorplace)
2024-05-08 20:00
PMV Pharmaceuticals Reports First Quarter 2024 Financial Results and Corporate Highlights(Globenewswire)
2024-03-26 20:00
PMV Pharmaceuticals Announces First Patient Dosed in Global Tumor-Agnostic Phase 2 PYNNACLE Trial for Rezatapopt in TP53 Y220C-Positive Solid Tumors(Globenewswire)
2024-03-18 04:01
PMV Pharmaceuticals PYNNACLE Phase I Data of Rezatapopt in Advanced Ovarian Cancer Featured in Late-Breaking Oral Presentation at 2024 SGO Annual Meeting on Women's Cancer(Globenewswire)
2024-02-29 21:21
PMV Pharmaceuticals Inc (PMVP) Reports Full Year 2023 Financial Results(Yahoo Finance)
2024-02-29 03:01
PMV Pharmaceuticals Reports Full Year 2023 Financial Results and Corporate Highlights(Globenewswire)
2024-02-25 19:00
PMV Pharmaceuticals to Participate in the TD Cowen 44th Annual Health Care Conference(Globenewswire)
2024-01-18 03:01
PMV Pharmaceuticals Announces Prioritization of PC14586 Clinical Development and Extended Cash Runway(Globenewswire)
2024-01-05 03:01
PMV Pharmaceuticals Strengthens Leadership with Key Appointments as Company Advances into Late-Stage Development(Globenewswire)
2023-11-08 20:41
PMV Pharmaceuticals Inc (PMVP) Reports Q3 2023 Financial Results and Corporate Updates(Yahoo Finance)
2023-11-08 19:00
PMV Pharmaceuticals Reports Third Quarter 2023 Financial Results and Corporate Highlights(Globenewswire)
2023-10-15 21:35
PMV Pharmaceuticals, Inc. (PMVP) Loses -70.19% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner(Yahoo Finance)
2023-10-12 00:30
PMV Pharmaceuticals Updated PC14586 Phase 1 Data Demonstrated Anti-Tumor Activity Across Multiple Solid Tumor Types With a TP53 Y220C Mutation(Globenewswire)
2023-10-11 00:00
PMV Pharmaceuticals to Present Updated Phase 1 Data on PC14586 at the 2023 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics and Host a KOL Webinar(Globenewswire)
2023-10-05 21:55
Wall Street Analysts See a 239.26% Upside in PMV Pharmaceuticals, Inc. (PMVP): Can the Stock Really Move This High?(Yahoo Finance)
2023-09-20 04:05
PMV Pharmaceuticals to Present Updated Phase 1 Data on PC14586 at the 2023 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics(Yahoo Finance)
2023-08-29 21:55
Wall Street Analysts Think PMV Pharmaceuticals, Inc. (PMVP) Could Surge 182.64%: Read This Before Placing a Bet(Yahoo Finance)
2023-08-28 21:55
PMV Pharmaceuticals, Inc. (PMVP)'s Technical Outlook is Bright After Key Golden Cross(Yahoo Finance)
2023-08-08 20:00
PMV Pharmaceuticals Reports Second Quarter 2023 Financial Results and Corporate Highlights(Yahoo Finance)
2023-06-06 04:01
PMV Pharmaceuticals to Participate in the Goldman Sachs Global Healthcare Conference(Yahoo Finance)
2023-05-09 20:00
PMV Pharmaceuticals Reports First Quarter 2023 Financial Results and Corporate Highlights(Yahoo Finance)
2023-04-13 23:51
We Think PMV Pharmaceuticals (NASDAQ:PMVP) Can Afford To Drive Business Growth(Yahoo Finance)
2023-02-28 19:00
PMV Pharmaceuticals Reports Full Year 2022 Financial Results and Corporate Highlights(Yahoo Finance)
2023-02-28 03:05
PMV Pharmaceuticals to Participate at Upcoming Investor Conferences in March(Yahoo Finance)

Page 1 of 3

previousnext

Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment. Kavout and its partners are participants in a number of affiliate advertising programs. As an Amazon Associate, Kavout or its partners earn from qualifying purchases from affiliate links. We also participate in other affiliate and advertising programs that provide a means for us to earn advertising fees by advertising and linking to third-party websites.